speb/financial-data huggingface dataset:
Financial ratios for CCTG — annual report dated 2025-03-31
Total revenue: 2266258.2262210795
Gross profit: 640642.9305912596
Operating income: -226148.32904884318
Net income: -181293.70179948586
Capital expenditures: 108837.14652956298
Operating cash flow: -124525.44987146529
Depreciation & amortization: 97432.51928020566
Net tangible assets: 1367890.7455012854
Owner earnings: -192698.32904884318
Return on net tangible assets (%): -14.087260234970433
Buffett classification: The Gruesome
Stock price: 16
Shares outstanding: 3413495
Book value: 1378675.5784061695
P/B ratio: 39.61477294255058
Market cap (USD): 54615920
Debt to equity: 0.11844719644500666
Current ratio: 2.349634422756385
Quick ratio: 1.890560808858379
COGS to revenue (%): 71.73124742896077
R&D to revenue (%): 3.7094938493283243
SG&A to revenue (%): 35.713682491592174
Free cash flow (dilution-adjusted): -239105.52699228792
Buyback yield (%): 0
Retained earnings: 910195.1156812339
Inventory turnover: 7.178290803005881
Receivables turnover: 5.342091947726455
Capitalized R&D asset: 180513.30611616746
ROCI (R&D-adjusted, %): -14.571277106249775
Rosenberg metric: 1.8395080182694348
FCF margin (%): -10.55067442120175
Revenue growth (%): 20.315561246057683
Rule of 40 score: 9.764886824855934
Financial ratios for CCTG — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 1367890.7455012854
Buffett classification: The Gruesome
Stock price: 16
Shares outstanding: 3413495
Book value: 1378675.5784061695
P/B ratio: 39.61477294255058
Market cap (USD): 54615920
Debt to equity: 0.11844719644500666
Current ratio: 2.349634422756385
Quick ratio: 1.890560808858379
Buyback yield (%): 0
Retained earnings: 910195.1156812339
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCTG — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 1270472.4935732647
Buffett classification: The Gruesome
Stock price: 13.6
Shares outstanding: 3413495
Book value: 1283139.9742930592
P/B ratio: 36.17963194200762
Market cap (USD): 46423532
Debt to equity: 0.11383616808421741
Current ratio: 1.8386159357497578
Quick ratio: 1.426831639621785
Buyback yield (%): 0
Retained earnings: 785369.5372750643
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COGT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.58
Shares outstanding: 170868004
Market cap (USD): 1466047474.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COGT — annual report dated 2022-12-31
Total revenue: 0
Operating income: -147839000
Net income: -140241000
Capital expenditures: 6863000
Operating cash flow: -118638000
Depreciation & amortization: 5878000
Net tangible assets: 255735000
Owner earnings: -141226000
Return on net tangible assets (%): -55.22357127495259
Buffett classification: The Gruesome
Stock price: 11.56
Shares outstanding: 170868004
Book value: 255735000
P/B ratio: 7.723753597434845
Market cap (USD): 1975234126.24
Debt to equity: 0.07683344086652198
Current ratio: 9.868747439383217
Quick ratio: 9.868747439383217
Free cash flow (dilution-adjusted): -143869000
Buyback yield (%): 0
Retained earnings: -411214000
Capitalized R&D asset: 121627000
ROCI (R&D-adjusted, %): -16.874711400076176
Rule of 40 score: 0
Financial ratios for COGT — annual report dated 2023-12-31
Total revenue: 0
Operating income: -208130000
Net income: -192410000
Capital expenditures: 2796000
Operating cash flow: -153624000
Depreciation & amortization: 3588000
Net tangible assets: 257802000
Owner earnings: -191618000
Return on net tangible assets (%): -74.32758473557226
Buffett classification: The Gruesome
Stock price: 5.88
Shares outstanding: 170868004
Book value: 257802000
P/B ratio: 3.8971918895896853
Market cap (USD): 1004703863.52
Debt to equity: 0.07312976625472262
Current ratio: 7.094188849297841
Quick ratio: 7.094188849297841
Free cash flow (dilution-adjusted): -187041000
Buyback yield (%): 0
Retained earnings: -603624000
Capitalized R&D asset: 255245090
ROCI (R&D-adjusted, %): -25.039045931214886
Rule of 40 score: 0
Financial ratios for COGT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.8
Shares outstanding: 170868004
Market cap (USD): 1845374443.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COGT — annual report dated 2024-12-31
Total revenue: 0
Operating income: -275939000
Net income: -255859000
Capital expenditures: 573000
Operating cash flow: -207791000
Depreciation & amortization: 4351000
Net tangible assets: 256286000
Owner earnings: -252081000
Return on net tangible assets (%): -98.35925489492207
Buffett classification: The Gruesome
Stock price: 7.8
Shares outstanding: 170868004
Book value: 256286000
P/B ratio: 5.2003247590582395
Market cap (USD): 1332770431.2
Debt to equity: 0.06815432758714873
Current ratio: 5.321701669359181
Quick ratio: 5.321701669359181
Free cash flow (dilution-adjusted): -248104000
Buyback yield (%): 0
Retained earnings: -859483000
Capitalized R&D asset: 389210760
ROCI (R&D-adjusted, %): -33.15614521764954
Rule of 40 score: 0
Financial ratios for COGT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.8
Shares outstanding: 170868004
Market cap (USD): 1332770431.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COGT — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -74933000
Net income: -71986000
Capital expenditures: 547000
Operating cash flow: -66511000
Depreciation & amortization: 1138000
Net tangible assets: 218995000
Owner earnings: -71395000
Return on net tangible assets (%): -32.601200940660746
Buffett classification: The Gruesome
Stock price: 5.99
Shares outstanding: 170868004
Book value: 218995000
P/B ratio: 4.673619689764607
Market cap (USD): 1023499343.96
Debt to equity: 0.0780428776912715
Current ratio: 5.127620746988929
Quick ratio: 5.127620746988929
Free cash flow (dilution-adjusted): -77066000
Buyback yield (%): 0
Retained earnings: -931469000
Capitalized R&D asset: 63029000
ROCI (R&D-adjusted, %): -11.063082685453773
Rule of 40 score: 0
Financial ratios for COGT — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -75582000
Net income: -73529000
Capital expenditures: 131000
Operating cash flow: -54542000
Depreciation & amortization: 1157000
Net tangible assets: 155036000
Owner earnings: -72503000
Return on net tangible assets (%): -46.76526742176011
Buffett classification: The Gruesome
Stock price: 7.18
Shares outstanding: 170868004
Book value: 155036000
P/B ratio: 7.9132089883639924
Market cap (USD): 1226832268.72
Debt to equity: 0.39125106426894396
Current ratio: 4.193762623669166
Quick ratio: 4.193762623669166
Interest coverage ratio: -240.70700636942675
Free cash flow (dilution-adjusted): -64389000
Buyback yield (%): 0
Retained earnings: -1004998000
Capitalized R&D asset: 104432430
ROCI (R&D-adjusted, %): -17.18151094499619
Rule of 40 score: 0
Financial ratios for COGT — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -83355000
Net income: -80930000
Capital expenditures: 65000
Operating cash flow: -64286000
Depreciation & amortization: 1147000
Net tangible assets: 302464000
Owner earnings: -79848000
Return on net tangible assets (%): -26.399174777824797
Buffett classification: The Gruesome
Stock price: 14.36
Shares outstanding: 170868004
Book value: 302464000
P/B ratio: 8.11225315224291
Market cap (USD): 2453664537.44
Debt to equity: 0.2002188690224291
Current ratio: 6.3818397969347425
Quick ratio: 6.3818397969347425
Interest coverage ratio: -57.13159698423578
Free cash flow (dilution-adjusted): -74955000
Buyback yield (%): 0
Retained earnings: -1085928000
Capitalized R&D asset: 131464580
ROCI (R&D-adjusted, %): -15.976185178149557
Rule of 40 score: 0
Financial ratios for COGT — annual report dated 2025-12-31
Total revenue: 0
Operating income: -333363000
Net income: -328937000
Capital expenditures: 1554000
Operating cash flow: -264444000
Depreciation & amortization: 4583000
Net tangible assets: 636371000
Owner earnings: -325908000
Return on net tangible assets (%): -51.21352167210637
Buffett classification: The Gruesome
Stock price: 35.52
Shares outstanding: 170868004
Book value: 636371000
P/B ratio: 9.537253429336033
Market cap (USD): 6069231502.080001
Debt to equity: 0.37524808641500007
Current ratio: 14.234750519913062
Quick ratio: 14.234750519913062
Interest coverage ratio: -108.87099934683214
Free cash flow (dilution-adjusted): -312077000
Buyback yield (%): 0
Retained earnings: -1188420000
Capitalized R&D asset: 483000010
ROCI (R&D-adjusted, %): -21.300984962751603
Rule of 40 score: 0
Financial ratios for COGT — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -99493000
Net income: -102492000
Capital expenditures: 811000
Operating cash flow: -79105000
Depreciation & amortization: 1141000
Net tangible assets: 636371000
Owner earnings: -102162000
Return on net tangible assets (%): -16.05384280553325
Buffett classification: The Gruesome
Stock price: 35.52
Shares outstanding: 170868004
Book value: 636371000
P/B ratio: 9.537253429336033
Market cap (USD): 6069231502.080001
Debt to equity: 0.37524808641500007
Current ratio: 14.234750519913062
Quick ratio: 14.234750519913062
Interest coverage ratio: -77.18619084561676
Free cash flow (dilution-adjusted): -95667000
Buyback yield (%): 0
Retained earnings: -1188420000
Capitalized R&D asset: 142308620
ROCI (R&D-adjusted, %): -9.139214196679795
Rule of 40 score: 0
Financial ratios for CRN.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.010270270270270271
Shares outstanding: 621161587
Market cap (USD): 6379497.380000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRN.L — annual report dated 2022-12-31
Total revenue: 656762765.9574468
Gross profit: 142774468.0851064
Operating income: 109608510.63829789
Net income: 86202127.65957448
Capital expenditures: 5960638.29787234
Operating cash flow: 99885106.38297872
Depreciation & amortization: 1878723.4042553192
Net tangible assets: 796573404.2553192
Owner earnings: 82120212.76595746
Return on net tangible assets (%): 10.309183350494605
Capex to operating income (%): 5.438116313378367
Buffett classification: The Great
Stock price: 0.008072289156626507
P/E ratio: 0.05816789073994608
Shares outstanding: 621161587
Book value: 799810638.2978723
P/B ratio: 0.006269228868878314
Market cap (USD): 5014195.943253012
Debt to equity: 0.2364761871826044
Current ratio: 10.82237159489274
Quick ratio: 0.45195596007675753
Effective tax rate (%): 13.310938034919548
Interest coverage ratio: 11.717502558853633
COGS to revenue (%): 78.26087660786223
SG&A to revenue (%): 1.8451236480674877
Free cash flow (dilution-adjusted): 86353191.4893617
Buyback yield (%): 1594.260826797011
Retained earnings: 573106382.9787234
Inventory turnover: 0.4994603769917981
Receivables turnover: 175.5351151549616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.0550779623772
FCF margin (%): 13.14830802922782
Rule of 40 score: 13.14830802922782
Financial ratios for CRN.L — annual report dated 2023-12-31
Total revenue: 740896666.6666666
Gross profit: 164020000
Operating income: 125987777.77777778
Net income: 94924444.44444445
Capital expenditures: 1876666.6666666665
Operating cash flow: 118912222.22222222
Depreciation & amortization: 2410000
Net tangible assets: 836612222.2222222
Owner earnings: 95457777.77777778
Return on net tangible assets (%): 11.410038634652189
Capex to operating income (%): 1.4895624796056055
Buffett classification: The Great
Stock price: 0.013164556962025314
P/E ratio: 0.08614553545761762
Shares outstanding: 621161587
Book value: 841291111.1111112
P/B ratio: 0.009719961362581837
Market cap (USD): 8177317.094683543
Debt to equity: 0.23806662246652632
Current ratio: 8.877525526359165
Quick ratio: 0.6933280126308848
Effective tax rate (%): 14.072196574233326
Interest coverage ratio: 8.3762281155352
COGS to revenue (%): 77.86196005740791
SG&A to revenue (%): 1.7562803029962195
Free cash flow (dilution-adjusted): 107976666.66666667
Buyback yield (%): 623.5813241897474
Retained earnings: 604884444.4444444
Inventory turnover: 0.5503282217725566
Receivables turnover: 20.387910475142174
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.263215328992125
FCF margin (%): 14.573782218842934
Revenue growth (%): 12.810394417924575
Rule of 40 score: 27.38417663676751
Financial ratios for CRN.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 785192708.3333334
Buffett classification: The Gruesome
Stock price: 0.022500000000000003
Shares outstanding: 621161587
Book value: 789800000.0000001
P/B ratio: 0.017695790969232714
Market cap (USD): 13976135.707500001
Debt to equity: 0.24860064784333585
Current ratio: 7.526855989620873
Quick ratio: 1.312901830762577
Buyback yield (%): 0
Retained earnings: 571715625
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRN.L — annual report dated 2024-12-31
Total revenue: 895698958.3333334
Gross profit: 194751041.6666667
Operating income: 156257291.6666667
Net income: 119345833.33333334
Capital expenditures: 2765625
Operating cash flow: 140270833.33333334
Depreciation & amortization: 2841666.666666667
Net tangible assets: 785192708.3333334
Owner earnings: 119421875.00000001
Return on net tangible assets (%): 15.209244015203275
Capex to operating income (%): 1.7699174038544867
Buffett classification: The Great
Stock price: 0.022500000000000003
P/E ratio: 0.11710618893970604
Shares outstanding: 621161587
Book value: 789800000.0000001
P/B ratio: 0.017695790969232714
Market cap (USD): 13976135.707500001
Debt to equity: 0.24860064784333585
Current ratio: 7.526855989620873
Quick ratio: 1.312901830762577
Effective tax rate (%): 15.051307906756033
Interest coverage ratio: 10.199700822737473
COGS to revenue (%): 78.25708740031936
SG&A to revenue (%): 1.4273071193237123
Free cash flow (dilution-adjusted): 129358333.33333336
Buyback yield (%): 563.4381108487815
Retained earnings: 571715625
Inventory turnover: 0.7805257712347644
Receivables turnover: 11.699721069460507
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.068568882204676
FCF margin (%): 14.442166324948744
Revenue growth (%): 20.893911206691005
Rule of 40 score: 35.336077531639745
Financial ratios for CRN.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 893258823.5294118
Buffett classification: The Gruesome
Stock price: 0.024246575342465753
Shares outstanding: 621161587
Book value: 898316470.5882354
P/B ratio: 0.01676585224935131
Market cap (USD): 15061041.219041096
Debt to equity: 0.46829821535447347
Current ratio: 7.091851643720146
Quick ratio: 1.2752570946895196
Buyback yield (%): 0
Retained earnings: 656084705.882353
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSTM — annual report dated 2021-12-31
Operating income: 622721405.7613637
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 17.91
Shares outstanding: 136150450
Market cap (USD): 2438454559.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSTM — annual report dated 2022-12-31
Total revenue: 9076595744.680851
Gross profit: 1024468085.1063831
Operating income: 364893617.0212766
Net income: 335106382.9787234
Capital expenditures: 302127659.5744681
Operating cash flow: 388297872.34042555
Depreciation & amortization: 308510638.29787236
Net tangible assets: 227028844.9893617
Owner earnings: 341489361.70212775
Return on net tangible assets (%): 150.41672863997942
Capex to operating income (%): 82.79883381924198
Buffett classification: The Gruesome
Stock price: 11.83
P/E ratio: 4.806413441555556
Shares outstanding: 136150450
Book value: 857918047.3723402
P/B ratio: 1.8774052235329264
Market cap (USD): 1610659823.5
Debt to equity: 2.734042553207716
Current ratio: 1.2155020551936797
Quick ratio: 0.44039929536185407
Effective tax rate (%): -109.99999999999999
Interest coverage ratio: 3.4646464646464645
COGS to revenue (%): 88.71308016877639
R&D to revenue (%): 0.5391467416783873
SG&A to revenue (%): 3.3286451007969995
Free cash flow (dilution-adjusted): 80851063.82978724
Buyback yield (%): 0
Retained earnings: 351381327.9148936
Inventory turnover: 5.346982431835425
Receivables turnover: 14.983059660951048
Capitalized R&D asset: 48936170.21276596
ROCI (R&D-adjusted, %): 10.620287417115613
FCF margin (%): 0.8907641819034225
Rule of 40 score: 0.8907641819034225
Financial ratios for CSTM — annual report dated 2023-12-31
Total revenue: 8695555555.555555
Gross profit: 1172222222.222222
Operating income: 428888888.8888889
Net income: 174444444.44444445
Capital expenditures: 405555555.5555555
Operating cash flow: 480000000
Depreciation & amortization: 333333333.3333333
Net tangible assets: 636666666.6666666
Owner earnings: 102222222.22222227
Return on net tangible assets (%): 16.055846422338576
Capex to operating income (%): 94.55958549222797
Buffett classification: The Gruesome
Stock price: 19.96
P/E ratio: 15.578386521019107
Shares outstanding: 136150450
Book value: 824444444.4444437
P/B ratio: 3.296235422911054
Market cap (USD): 2717562982
Debt to equity: 2.6239892183288434
Current ratio: 1.2802056555269925
Quick ratio: 0.5109254498714654
Effective tax rate (%): 32.327586206896555
Interest coverage ratio: 3.607476635514019
COGS to revenue (%): 86.51929465882954
R&D to revenue (%): 0.6644518272425249
SG&A to revenue (%): 4.050600562228469
Free cash flow (dilution-adjusted): 73333333.33333333
Buyback yield (%): 0
Retained earnings: 223333333.3333333
Inventory turnover: 5.656641604010025
Receivables turnover: 14.738229755178907
Capitalized R&D asset: 90565011.82033098
ROCI (R&D-adjusted, %): 11.738754273815816
Rosenberg metric: 3.0193236714975793
FCF margin (%): 0.8433427038078201
Revenue growth (%): -4.198051778923792
Rule of 40 score: -3.354709075115972
Financial ratios for CSTM — quarterly report dated 2024-09-30
Operating income: 54603713.54444444
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.26
Shares outstanding: 136150450
Market cap (USD): 2213806317
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSTM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.27
Shares outstanding: 136150450
Market cap (USD): 1398265121.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSTM — annual report dated 2024-12-31
Total revenue: 7640625000
Gross profit: 977083333.3333334
Operating income: 283333333.3333334
Net income: 62500000
Capital expenditures: 417708333.3333334
Operating cash flow: 313541666.6666667
Depreciation & amortization: 316666666.6666667
Net tangible assets: 586458333.3333334
Owner earnings: -38541666.66666669
Return on net tangible assets (%): -6.57193605683837
Capex to operating income (%): 147.42647058823528
Buffett classification: The Gruesome
Stock price: 10.27
P/E ratio: 22.372241944
Shares outstanding: 136150450
Book value: 757291666.6666665
P/B ratio: 1.846402361265475
Market cap (USD): 1398265121.5
Debt to equity: 2.638239339752408
Current ratio: 1.2683264177040112
Quick ratio: 0.45159059474412167
Effective tax rate (%): 55.55555555555556
Interest coverage ratio: 2.6407766990291264
COGS to revenue (%): 87.21199727334698
R&D to revenue (%): 0.6680299931833675
SG&A to revenue (%): 4.267211997273347
Free cash flow (dilution-adjusted): -116666666.66666667
Buyback yield (%): 5.885269209775299
Retained earnings: 96875000
Inventory turnover: 5.416596104995766
Receivables turnover: 15.092592592592593
Capitalized R&D asset: 105901713.94799057
ROCI (R&D-adjusted, %): 7.98067513465808
Rosenberg metric: -3.377403846153843
FCF margin (%): -1.5269256987048399
Revenue growth (%): -12.131836187068743
Rule of 40 score: -13.658761885773583
Financial ratios for CSTM — quarterly report dated 2025-03-31
Total revenue: 2151086956.521739
Gross profit: 285869565.2173913
Operating income: 105434782.60869564
Net income: 41304347.82608695
Capital expenditures: 66304347.82608695
Operating cash flow: 63043478.26086956
Depreciation & amortization: 84782608.69565217
Net tangible assets: 657608695.6521739
Owner earnings: 59782608.69565217
Return on net tangible assets (%): 9.090909090909092
Capex to operating income (%): 62.88659793814433
Buffett classification: The Good
Stock price: 10.09
P/E ratio: 8.314851297763157
Shares outstanding: 136150450
Book value: 831521739.130435
P/B ratio: 1.6521011728888886
Market cap (USD): 1373758040.5
Debt to equity: 2.6941176470588224
Current ratio: 1.236725663716814
Quick ratio: 0.529867256637168
Effective tax rate (%): 38.70967741935484
Interest coverage ratio: 97
COGS to revenue (%): 86.71045982819606
R&D to revenue (%): 0.6568974229408793
SG&A to revenue (%): 3.789792824658919
Free cash flow (dilution-adjusted): -11956521.739130434
Buyback yield (%): 1.1868427587257462
Retained earnings: 126086956.52173913
Inventory turnover: 1.3427230046948355
Receivables turnover: 2.419315403422983
Capitalized R&D asset: 14130434.782608695
ROCI (R&D-adjusted, %): 3.1327206245676456
FCF margin (%): -0.5558362809499747
Rule of 40 score: -0.5558362809499747
Financial ratios for CSTM — quarterly report dated 2025-06-30
Total revenue: 2474117647.0588236
Gross profit: 309411764.7058824
Operating income: 100000000
Net income: 42352941.17647059
Capital expenditures: 85882352.94117647
Operating cash flow: 134117647.05882353
Depreciation & amortization: 96470588.23529412
Net tangible assets: 752941176.4705882
Owner earnings: 52941176.47058824
Return on net tangible assets (%): 7.03125
Capex to operating income (%): 85.88235294117648
Buffett classification: The Gruesome
Stock price: 13.3
P/E ratio: 21.64546576383369
Shares outstanding: 136150450
Book value: 940000000
P/B ratio: 1.9263840265957448
Market cap (USD): 1810800985
Debt to equity: 2.690863579474343
Current ratio: 1.2343833422317136
Quick ratio: 0.5253603844100373
Effective tax rate (%): 35.71428571428571
Interest coverage ratio: 3.1481481481481484
COGS to revenue (%): 87.49405611031858
R&D to revenue (%): 0.5706134094151213
SG&A to revenue (%): 3.994293865905849
Free cash flow (dilution-adjusted): 43529411.76470588
Buyback yield (%): 2.273936833993676
Retained earnings: 178823529.4117647
Inventory turnover: 1.3855421686746987
Receivables turnover: 2.612422360248447
Capitalized R&D asset: 23585038.363171354
ROCI (R&D-adjusted, %): 2.5318685541420494
Rosenberg metric: 1.6660633484162903
FCF margin (%): 1.759391345696624
Revenue growth (%): 15.01709122254259
Rule of 40 score: 16.776482568239214
Financial ratios for CSTM — quarterly report dated 2025-09-30
Total revenue: 2548235294.117647
Gross profit: 369411764.7058824
Operating income: 156470588.23529413
Net income: 103529411.76470588
Capital expenditures: 81176470.58823529
Operating cash flow: 116470588.23529412
Depreciation & amortization: 98823529.41176471
Net tangible assets: 832941176.4705882
Owner earnings: 121176470.58823529
Return on net tangible assets (%): 14.548022598870055
Capex to operating income (%): 51.87969924812029
Buffett classification: The Good
Stock price: 14.88
P/E ratio: 10.822984152698456
Shares outstanding: 136150450
Book value: 1015294117.6470585
P/B ratio: 1.9954008013904991
Market cap (USD): 2025918696
Debt to equity: 2.470451911935111
Current ratio: 1.2774158523344192
Quick ratio: 0.5358306188925082
Effective tax rate (%): 30.15873015873016
Interest coverage ratio: 4.9259259259259265
COGS to revenue (%): 85.50323176361957
R&D to revenue (%): 0.554016620498615
SG&A to revenue (%): 3.9242843951985225
Free cash flow (dilution-adjusted): 28235294.11764706
Buyback yield (%): 1.4517741883696182
Retained earnings: 282352941.1764706
Inventory turnover: 1.355783308931186
Receivables turnover: 2.6446886446886446
Capitalized R&D asset: 28239514.066496167
ROCI (R&D-adjusted, %): 3.739000356909673
Rosenberg metric: 4.25
FCF margin (%): 1.10803324099723
Revenue growth (%): 2.995720399429389
Rule of 40 score: 4.1037536404266195
Financial ratios for CSTM — quarterly report dated 2025-12-31
Total revenue: 2589411764.7058825
Gross profit: 408235294.11764705
Operating income: 195294117.6470588
Net income: 132941176.47058824
Capital expenditures: 127058823.52941176
Operating cash flow: 256470588.23529413
Depreciation & amortization: 101176470.5882353
Net tangible assets: 961176470.5882354
Owner earnings: 107058823.52941176
Return on net tangible assets (%): 11.138310893512852
Capex to operating income (%): 65.06024096385542
Buffett classification: The Good
Stock price: 18.85
P/E ratio: 8.016908757350006
Shares outstanding: 136150450
Book value: 1142352941.1764708
P/B ratio: 2.2466226417353243
Market cap (USD): 2566435982.5
Debt to equity: 2.0020597322348093
Current ratio: 1.2914349276974415
Quick ratio: 0.5088987764182423
Effective tax rate (%): 31.097560975609756
Interest coverage ratio: 6.384615384615384
COGS to revenue (%): 84.23443889141299
R&D to revenue (%): 0.6360745115856429
SG&A to revenue (%): 3.6801453884597906
Free cash flow (dilution-adjusted): 128235294.11764707
Buyback yield (%): 1.8336254576500726
Retained earnings: 416470588.2352941
Inventory turnover: 1.3176972281449892
Receivables turnover: 3.0442600276625176
Capitalized R&D asset: 30588235.294117644
ROCI (R&D-adjusted, %): 4.671505676530802
Rosenberg metric: 2.7499999999999982
FCF margin (%): 4.952294411631077
Revenue growth (%): 1.6158818097876302
Rule of 40 score: 6.568176221418707
Financial ratios for CSTM — annual report dated 2025-12-31
Total revenue: 9940000000
Gross profit: 1396470588.235294
Operating income: 557647058.8235295
Net income: 323529411.7647059
Capital expenditures: 365882352.9411765
Operating cash flow: 575294117.6470588
Depreciation & amortization: 388235294.11764705
Net tangible assets: 961176470.5882354
Owner earnings: 345882352.9411765
Return on net tangible assets (%): 35.98531211750306
Capex to operating income (%): 65.61181434599155
Buffett classification: The Good
Stock price: 18.85
P/E ratio: 7.932620309545455
Shares outstanding: 136150450
Book value: 1142352941.1764708
P/B ratio: 2.2466226417353243
Market cap (USD): 2566435982.5
Debt to equity: 2.0020597322348093
Current ratio: 1.2914349276974415
Quick ratio: 0.5088987764182423
Effective tax rate (%): 32.59803921568628
Interest coverage ratio: 4.471698113207547
COGS to revenue (%): 85.9510001183572
R&D to revenue (%): 0.6036217303822937
SG&A to revenue (%): 3.929459107586696
Free cash flow (dilution-adjusted): 187058823.52941176
Buyback yield (%): 5.271673190743958
Retained earnings: 416470588.2352941
Inventory turnover: 5.161336176261549
Receivables turnover: 11.686030428769017
Capitalized R&D asset: 113264583.33333334
ROCI (R&D-adjusted, %): 13.064948222228479
Rosenberg metric: 8.216566626650659
FCF margin (%): 1.8818795123683274
Revenue growth (%): 30.09406952965235
Rule of 40 score: 31.97594904202068
Financial ratios for CTV.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -2633987.5
Net income: -2515444.117647059
Capital expenditures: 2089441.1764705882
Operating cash flow: -2296977.205882353
Net tangible assets: 29476237.499999996
Owner earnings: -4604885.294117647
Return on net tangible assets (%): -15.62236460510826
Buffett classification: The Gruesome
Stock price: 0.10294117647058824
Shares outstanding: 151323027
Book value: 29476237.499999996
P/B ratio: 0.5284721439251054
Market cap (USD): 15577370.426470589
Debt to equity: 0
Current ratio: 4.893493027530267
Quick ratio: 4.893493027530267
Free cash flow (dilution-adjusted): -5256734.558823529
Buyback yield (%): 0
Retained earnings: -2780622.058823529
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.935969185348029
Rule of 40 score: 0
Financial ratios for CTV.V — annual report dated 2024-03-31
Total revenue: 0
Gross profit: 0
Operating income: -1159957.7777777778
Net income: -1162770.3703703703
Capital expenditures: 701937.037037037
Operating cash flow: -876173.3333333333
Depreciation & amortization: 0
Net tangible assets: 16827132.592592593
Owner earnings: -1864707.4074074072
Return on net tangible assets (%): -11.081551756644876
Buffett classification: The Gruesome
Stock price: 0.058823529411764705
Shares outstanding: 151323027
Book value: 16827132.59259259
P/B ratio: 0.5289881969153911
Market cap (USD): 8901354.529411765
Debt to equity: 0
Current ratio: 4.621716156261943
Quick ratio: 4.621716156261943
Free cash flow (dilution-adjusted): -1896345.9259259258
Buyback yield (%): 0
Retained earnings: -4461554.074074074
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.893377534140299
Rule of 40 score: 0
Financial ratios for CTV.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 9011.111111111111
Buffett classification: The Gruesome
Stock price: 0.04444444444444444
Shares outstanding: 151323027
Market cap (USD): 6725467.866666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTV.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -8644.755244755244
Operating income: -340616.0839160839
Net income: -736934.2657342658
Capital expenditures: 218206.99300699303
Operating cash flow: -2226591.6083916086
Depreciation & amortization: 8644.755244755244
Net tangible assets: 8612092.307692308
Owner earnings: -946496.5034965037
Return on net tangible assets (%): -10.99032000215667
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 151323027
Book value: 8612092.307692308
P/B ratio: 0.4914963510406412
Market cap (USD): 4232811.944055945
Debt to equity: 0.325934293721984
Current ratio: 0.9166899109596267
Quick ratio: 0.9166899109596267
Interest coverage ratio: -9.223796087639895
Free cash flow (dilution-adjusted): -2507161.5384615385
Buyback yield (%): 0
Retained earnings: -14152779.02097902
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.95509095521243
Rule of 40 score: 0
Financial ratios for CTV.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -8848.951048951049
Operating income: -549132.1678321678
Net income: -470133.56643356645
Capital expenditures: 102061.53846153847
Operating cash flow: -618838.4615384616
Depreciation & amortization: 8848.951048951049
Net tangible assets: 8462108.391608393
Owner earnings: -563346.1538461539
Return on net tangible assets (%): -6.657278869233188
Buffett classification: The Gruesome
Stock price: 0.02097902097902098
Shares outstanding: 151323027
Book value: 8473336.363636363
P/B ratio: 0.3746586730188016
Market cap (USD): 3174608.958041958
Debt to equity: 0.3346075896986937
Current ratio: 0.7997137970839377
Quick ratio: 0.7997137970839377
Interest coverage ratio: -17.41807333141095
Free cash flow (dilution-adjusted): -771826.5734265734
Buyback yield (%): 0
Retained earnings: -14622912.587412588
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.480707766881401
Rule of 40 score: 0
Financial ratios for CTV.V — annual report dated 2025-03-31
Total revenue: 0
Gross profit: -26000.699300699303
Operating income: -1568951.7482517483
Net income: -10410955.944055945
Capital expenditures: 686726.5734265734
Operating cash flow: -2578088.111888112
Depreciation & amortization: 26000.699300699303
Net tangible assets: 8462108.391608393
Owner earnings: -11071681.818181818
Return on net tangible assets (%): -130.83833609554395
Buffett classification: The Gruesome
Stock price: 0.02097902097902098
Shares outstanding: 151323027
Book value: 8473336.363636363
P/B ratio: 0.3746586730188016
Market cap (USD): 3174608.958041958
Debt to equity: 0.3346075896986937
Current ratio: 0.7997137970839377
Quick ratio: 0.7997137970839377
Interest coverage ratio: -14.59110330699444
Free cash flow (dilution-adjusted): -3415167.832167832
Buyback yield (%): 0
Retained earnings: -14622912.587412588
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.51633973820469
Rule of 40 score: 0
Financial ratios for CTV.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -9590.510948905108
Operating income: -408845.2554744525
Net income: -739617.5182481752
Capital expenditures: 82262.04379562043
Operating cash flow: -689201.4598540146
Depreciation & amortization: 9590.510948905108
Net tangible assets: 8097172.262773722
Owner earnings: -812289.0510948905
Return on net tangible assets (%): -10.031762011898179
Buffett classification: The Gruesome
Stock price: 0.0218978102189781
Shares outstanding: 151323027
Book value: 8108891.970802919
P/B ratio: 0.40864312151875803
Market cap (USD): 3313642.927007299
Debt to equity: 0.35176019260464
Current ratio: 0.6768173874524759
Quick ratio: 0.6768173874524759
Interest coverage ratio: -10.759912402028585
Free cash flow (dilution-adjusted): -786392.7007299269
Buyback yield (%): 0
Retained earnings: -15703199.999999998
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.041937381168118
Rule of 40 score: 0
Financial ratios for CTV.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -5215.107913669065
Operating income: -1324909.3525179857
Net income: -1342287.7697841728
Capital expenditures: 828029.4964028777
Operating cash flow: -300415.8273381295
Depreciation & amortization: 5215.107913669065
Net tangible assets: 7627153.237410072
Owner earnings: -2165102.1582733816
Return on net tangible assets (%): -28.386766213819747
Buffett classification: The Gruesome
Stock price: 0.12230215827338131
Shares outstanding: 151323027
Book value: 7638704.316546762
P/B ratio: 2.422810470418587
Market cap (USD): 18507132.798561152
Debt to equity: 0.34707051809890166
Current ratio: 0.22850629654860083
Quick ratio: 0.22850629654860083
Interest coverage ratio: -36.53870878139756
Free cash flow (dilution-adjusted): -1956635.2517985613
Buyback yield (%): 0
Retained earnings: -16819542.446043167
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.344686973260657
Rule of 40 score: 0
Financial ratios for CTV.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -5381.021897810218
Operating income: -366162.7737226277
Net income: -150575.91240875912
Capital expenditures: 136165.69343065692
Operating cash flow: -57497.8102189781
Depreciation & amortization: 5381.021897810218
Net tangible assets: 7831167.153284671
Owner earnings: -281360.5839416058
Return on net tangible assets (%): -3.592830780321081
Buffett classification: The Gruesome
Stock price: 0.0948905109489051
Shares outstanding: 151323027
Book value: 7842886.861313868
P/B ratio: 1.8308461672695189
Market cap (USD): 14359119.350364963
Debt to equity: 0.3424243735664517
Current ratio: 0.2520617710784057
Quick ratio: 0.2520617710784057
Interest coverage ratio: -9.915460942441493
Free cash flow (dilution-adjusted): -251009.48905109486
Buyback yield (%): 0
Retained earnings: -17215659.12408759
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.668724414842405
Rule of 40 score: 0
Financial ratios for CVV.V — annual report dated 2022-04-30
Total revenue: 0
Gross profit: -82031.25
Operating income: -5775000
Net income: -4831250
Capital expenditures: 275000
Operating cash flow: -4600781.25
Depreciation & amortization: 82031.25
Net tangible assets: 11001562.5
Owner earnings: -5024218.75
Return on net tangible assets (%): -45.668228944752165
Buffett classification: The Gruesome
Stock price: 0.328125
Shares outstanding: 220115341
Book value: 11001562.5
P/B ratio: 6.565008040051129
Market cap (USD): 72225346.265625
Debt to equity: 0.02165885527623917
Current ratio: 8.132368703108252
Quick ratio: 8.132368703108252
Interest coverage ratio: -308
Free cash flow (dilution-adjusted): -5900781.25
Buyback yield (%): 0
Retained earnings: -77909375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -51.605696732756215
Rule of 40 score: 0
Financial ratios for CVV.V — annual report dated 2023-04-30
Total revenue: 0
Gross profit: -123529.41176470587
Operating income: -9389705.88235294
Net income: -6816176.470588235
Capital expenditures: 205882.35294117645
Operating cash flow: -9176470.588235293
Depreciation & amortization: 123529.41176470587
Net tangible assets: 8880147.05882353
Owner earnings: -6898529.4117647065
Return on net tangible assets (%): -77.68485551047446
Buffett classification: The Gruesome
Stock price: 0.2426470588235294
Shares outstanding: 220115341
Book value: 8880147.05882353
P/B ratio: 6.014578333195329
Market cap (USD): 53410340.09558824
Debt to equity: 0.07005050923242526
Current ratio: 5.315562524500196
Quick ratio: 5.315562524500196
Interest coverage ratio: -296.9767441860465
Free cash flow (dilution-adjusted): -10725735.294117646
Buyback yield (%): 0
Retained earnings: -80142647.05882353
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -99.49357226334243
Rule of 40 score: 0
Financial ratios for CVV.V — annual report dated 2024-04-30
Total revenue: 0
Gross profit: -143065.69343065692
Operating income: -7583941.605839415
Net income: -5866423.357664233
Capital expenditures: 200729.92700729927
Operating cash flow: -8381751.824817518
Depreciation & amortization: 143065.69343065692
Net tangible assets: 10248175.18248175
Owner earnings: -5924087.591240875
Return on net tangible assets (%): -57.80626780626781
Buffett classification: The Gruesome
Stock price: 0.43065693430656926
Shares outstanding: 220115341
Book value: 10248175.18248175
P/B ratio: 9.249861195868945
Market cap (USD): 94794197.9489051
Debt to equity: 0.0542022792022792
Current ratio: 12.039264828738512
Quick ratio: 12.039264828738512
Interest coverage ratio: -152.79411764705884
Free cash flow (dilution-adjusted): -9308759.12408759
Buyback yield (%): 0
Retained earnings: -86983211.67883211
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -70.67065705346211
Rule of 40 score: 0
Financial ratios for CVV.V — quarterly report dated 2024-10-31
Capital expenditures: 0
Depreciation & amortization: 32374.100719424463
Buffett classification: The Gruesome
Stock price: 0.5323741007194245
Shares outstanding: 220115341
Market cap (USD): 117183706.71942447
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVV.V — quarterly report dated 2025-01-31
Total revenue: 0
Gross profit: -31724.137931034486
Operating income: -4114482.7586206896
Net income: -3435862.0689655175
Capital expenditures: 0
Operating cash flow: 62758.620689655174
Depreciation & amortization: 31724.137931034486
Net tangible assets: 13893793.103448275
Owner earnings: -3404137.931034483
Return on net tangible assets (%): -24.501141665839373
Buffett classification: The Gruesome
Stock price: 0.6206896551724138
Shares outstanding: 220115341
Book value: 13893793.103448275
P/B ratio: 9.833406477712698
Market cap (USD): 136623315.10344827
Debt to equity: 0.035292365730169764
Current ratio: 3.6523522975929974
Quick ratio: 3.6523522975929974
Interest coverage ratio: -397.73333333333335
Free cash flow (dilution-adjusted): -1580000
Buyback yield (%): 0
Retained earnings: -87848275.86206897
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -28.757350814614867
Rule of 40 score: 0
Financial ratios for CVV.V — quarterly report dated 2025-04-30
Total revenue: 0
Gross profit: -34057.97101449276
Operating income: -2939855.0724637685
Net income: -1671014.4927536233
Capital expenditures: 1449.2753623188407
Operating cash flow: -6024637.681159421
Depreciation & amortization: 34057.97101449276
Net tangible assets: 14761594.202898553
Owner earnings: -1638405.7971014495
Return on net tangible assets (%): -11.099111482008738
Buffett classification: The Gruesome
Stock price: 0.5724637681159421
Shares outstanding: 220115341
Book value: 14761594.202898553
P/B ratio: 8.536209287222032
Market cap (USD): 126008057.52898553
Debt to equity: 0.03362623337096853
Current ratio: 10.094488188976378
Quick ratio: 10.094488188976378
Interest coverage ratio: -253.5625
Free cash flow (dilution-adjusted): -6037681.15942029
Buyback yield (%): 0
Retained earnings: -93975362.3188406
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.372552764778913
Rule of 40 score: 0
Financial ratios for CVV.V — annual report dated 2025-04-30
Total revenue: 0
Gross profit: -132608.69565217392
Operating income: -10147826.086956523
Net income: -7622463.768115942
Capital expenditures: 7971.014492753624
Operating cash flow: -9829710.144927537
Depreciation & amortization: 132608.69565217392
Net tangible assets: 14761594.202898553
Owner earnings: -7497826.086956522
Return on net tangible assets (%): -50.79279367728634
Buffett classification: The Gruesome
Stock price: 0.5724637681159421
Shares outstanding: 220115341
Book value: 14761594.202898553
P/B ratio: 8.536209287222032
Market cap (USD): 126008057.52898553
Debt to equity: 0.03362623337096853
Current ratio: 10.094488188976378
Quick ratio: 10.094488188976378
Interest coverage ratio: -222.2857142857143
Free cash flow (dilution-adjusted): -11580434.782608697
Buyback yield (%): 0
Retained earnings: -93975362.3188406
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -66.87040397287747
Rule of 40 score: 0
Financial ratios for CVV.V — quarterly report dated 2025-07-31
Total revenue: 0
Gross profit: -31884.057971014496
Operating income: -4784782.608695652
Net income: -3868840.579710145
Capital expenditures: 28260.869565217392
Operating cash flow: -1323913.043478261
Depreciation & amortization: 31884.057971014496
Net tangible assets: 13876086.95652174
Owner earnings: -3865217.3913043477
Return on net tangible assets (%): -27.855240482531723
Buffett classification: The Gruesome
Stock price: 0.7391304347826088
Shares outstanding: 220115341
Book value: 13876086.95652174
P/B ratio: 11.724771414695283
Market cap (USD): 162693947.6956522
Debt to equity: 0.034362107681863284
Current ratio: 8.109911299652913
Quick ratio: 8.109911299652913
Interest coverage ratio: -440.19999999999993
Free cash flow (dilution-adjusted): -3348550.7246376816
Buyback yield (%): 0
Retained earnings: -97844202.89855073
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.53308618150424
Rule of 40 score: 0
Financial ratios for CVV.V — quarterly report dated 2025-10-31
Total revenue: 0
Gross profit: -31428.57142857143
Operating income: -2507142.8571428573
Net income: -2367857.142857143
Capital expenditures: 8571.428571428572
Operating cash flow: -3492857.142857143
Depreciation & amortization: 31428.57142857143
Net tangible assets: 22763571.42857143
Owner earnings: -2345000.0000000005
Return on net tangible assets (%): -10.301546957858736
Buffett classification: The Gruesome
Stock price: 0.6785714285714286
Shares outstanding: 220115341
Book value: 22763571.42857143
P/B ratio: 6.56153547177508
Market cap (USD): 149363981.39285716
Debt to equity: 0.019768426998023156
Current ratio: 5.810126582278481
Quick ratio: 5.810126582278481
Interest coverage ratio: -250.71428571428572
Free cash flow (dilution-adjusted): -3511428.571428572
Buyback yield (%): 0
Retained earnings: -98815000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.840024706609018
Rule of 40 score: 0
Financial ratios for CVV.V — quarterly report dated 2026-01-31
Total revenue: 0
Gross profit: -33333.33333333333
Operating income: -5714074.074074074
Net income: -4722222.222222222
Capital expenditures: 0
Operating cash flow: -2157777.7777777775
Depreciation & amortization: 34074.07407407407
Net tangible assets: 27497037.037037034
Owner earnings: -4688148.148148148
Return on net tangible assets (%): -17.049648446970718
Buffett classification: The Gruesome
Stock price: 0.6666666666666666
Shares outstanding: 220115341
Book value: 27497037.037037037
P/B ratio: 5.336704477250073
Market cap (USD): 146743560.66666666
Debt to equity: 0.01635193017429487
Current ratio: 6.518787878787878
Quick ratio: 6.518787878787878
Interest coverage ratio: -593.3846153846154
Free cash flow (dilution-adjusted): -4935555.555555555
Buyback yield (%): 0
Retained earnings: -107197777.77777778
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.512684146146892
Rule of 40 score: 0
Financial ratios for DCI.L — annual report dated 2021-12-31
Total revenue: -26194594.594594594
Net income: -26990540.540540542
Capital expenditures: 4933783.783783784
Operating cash flow: -11724324.324324325
Depreciation & amortization: 64864.86486486487
Net tangible assets: 160928378.3783784
Owner earnings: -31859459.45945946
Return on net tangible assets (%): -19.797291056118635
Buffett classification: The Gruesome
Stock price: 0.0005405405405405405
Shares outstanding: 904627000
Book value: 173012162.16216218
P/B ratio: 0.0028263190370931583
Market cap (USD): 488987.5675675676
Debt to equity: 0.16254910996727304
Free cash flow (dilution-adjusted): -16658108.108108109
Buyback yield (%): 0
Retained earnings: -622148648.6486486
Receivables turnover: -87.710407239819
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCI.L — annual report dated 2022-12-31
Total revenue: -8757831.325301206
Net income: -6983132.530120483
Capital expenditures: 3932530.120481928
Operating cash flow: -14454216.86746988
Depreciation & amortization: 57831.32530120482
Net tangible assets: 135068674.6987952
Owner earnings: -10857831.325301206
Return on net tangible assets (%): -8.038748695442747
Buffett classification: The Gruesome
Stock price: 0.0004819277108433735
Shares outstanding: 904627000
Book value: 145237349.39759034
P/B ratio: 0.003001740400009955
Market cap (USD): 435964.8192771085
Debt to equity: 0.0667457506200901
Free cash flow (dilution-adjusted): -18386746.987951808
Buyback yield (%): 0
Retained earnings: -563028915.6626506
Receivables turnover: -0.7600376411543287
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCI.L — annual report dated 2023-12-31
Total revenue: 7160759.493670885
Net income: 2520253.164556962
Capital expenditures: 3125316.4556962023
Operating cash flow: -1465822.7848101265
Depreciation & amortization: 63291.13924050632
Net tangible assets: 160055696.20253164
Owner earnings: -541772.1518987343
Return on net tangible assets (%): -0.3384897662206195
Buffett classification: The Gruesome
Stock price: 0.0006329113924050633
P/E ratio: 0.22717905575087896
Shares outstanding: 904627000
Book value: 165474683.54430377
P/B ratio: 0.00346003824823102
Market cap (USD): 572548.7341772153
Debt to equity: 0.10693440428380188
COGS to revenue (%): 0
SG&A to revenue (%): 94.60844970832596
Free cash flow (dilution-adjusted): -4591139.240506329
Buyback yield (%): 0
Retained earnings: -589325316.4556962
Receivables turnover: 1.564868603042877
Capitalized R&D asset: 0
FCF margin (%): -64.11525543574332
Rule of 40 score: -64.11525543574332
Financial ratios for DEVIT.NS — annual report dated 2022-03-31
Total revenue: 13154252.93419491
Gross profit: 1410879.5991032573
Operating income: 648555.9804826586
Net income: 17671.10642226032
Capital expenditures: 203534.22128445207
Operating cash flow: 765620.466833707
Depreciation & amortization: 239825.9264143479
Net tangible assets: 4004760.6488197283
Owner earnings: 53962.81155215614
Return on net tangible assets (%): 1.3474665850020253
Capex to operating income (%): 31.382675884505893
Buffett classification: The Good
Stock price: 0.34419095344850326
P/E ratio: 1097.8305488059702
Shares outstanding: 56363714
Book value: 4322735.065277594
P/B ratio: 4.487871722092907
Market cap (USD): 19399880.46155875
Debt to equity: 0.29385008221652087
Current ratio: 1.5168046115195513
Quick ratio: 1.3725929008492472
Effective tax rate (%): 103.60667412758163
Interest coverage ratio: 6.933596503595094
COGS to revenue (%): 89.27434643258508
SG&A to revenue (%): 1.4260837484598796
Free cash flow (dilution-adjusted): 562086.2455492549
Buyback yield (%): 0
Retained earnings: 1545641.5666622708
Inventory turnover: 19.03469208900669
Receivables turnover: 3.2094589376954654
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.447453922668812
FCF margin (%): 4.273038144858028
Rule of 40 score: 4.273038144858028